Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-05-24 Sale |
2022-05-25 6:07 pm |
Vir Biotechnology Inc. | VIR | SATO VICKI L Director |
3,374 | $23.82 | $80,369 | 1,519,304 (Direct) |
View |
| 2022-05-24 Sale |
2022-05-25 5:49 pm |
Vir Biotechnology Inc. | VIR | Ramasastry Saira Director |
1,687 | $23.82 | $40,184 | 20,902 (Direct) |
View |
| 2022-05-09 Sale |
2022-05-10 5:44 pm |
Vir Biotechnology Inc. | VIR | SATO VICKI L Director |
14,541 | $20.62 | $299,835 | 1,503,463 (Direct) |
View |
| 2022-04-28 Sale |
2022-05-02 4:05 pm |
Vir Biotechnology Inc. | VIR | SATO VICKI L Director |
17,915 | $20.9 | $374,424 | 1,518,004 (Direct) |
View |
| 2022-03-30 Sale |
2022-03-31 2:46 pm |
Vir Biotechnology Inc. | VIR | HANLY ANN M. Chief Technology Officer |
2,627 | $26.24 | $68,925 | 81,485 (Indirect Direct) |
View |
| 2022-02-22 Sale |
2022-02-24 9:30 pm |
Vir Biotechnology Inc. | VIR | Virgin Herbert EVP, Research & CSO |
1,375 | $30 | $41,250 | 464,912 (Direct) |
View |
| 2022-02-17 Sale |
2022-02-22 5:02 pm |
Vir Biotechnology Inc. | VIR | Virgin Herbert EVP, Research & CSO |
2,293 | $31.93 | $73,218 | 105,407 (Direct) |
View |
| 2022-02-17 Sale |
2022-02-22 5:01 pm |
Vir Biotechnology Inc. | VIR | SCANGOS GEORGE A President and CEO |
27,750 | $31.11 | $863,378 | 5,704,138 (Indirect Direct) |
View |
| 2022-02-17 Sale |
2022-02-22 5:01 pm |
Vir Biotechnology Inc. | VIR | Rice Steven J. Chief Administrative Officer |
1,942 | $31.93 | $62,010 | 18,658 (Direct) |
View |
| 2022-02-17 Sale |
2022-02-22 5:00 pm |
Vir Biotechnology Inc. | VIR | Horn Howard CFO |
2,393 | $31.93 | $76,411 | 200,384 (Direct) |
View |
| 2022-02-16 Sale |
2022-02-18 4:47 pm |
Vir Biotechnology Inc. | VIR | Pang Phillip Chief Medical Officer |
8,009 | $31.69 | $253,780 | 142,359 (Direct) |
View |
| 2022-02-08 Sale |
2022-02-09 6:58 pm |
Vir Biotechnology Inc. | VIR | Virgin Herbert EVP, Research & CSO |
1,375 | $33.94 | $46,668 | 328,580 (Direct) |
View |
| 2022-02-02 Sale |
2022-02-04 5:03 pm |
Vir Biotechnology Inc. | VIR | Pang Phillip Chief Medical Officer |
5,000 | $34.52 | $172,620 | 150,368 (Direct) |
View |
| 2022-01-25 Sale |
2022-01-26 7:35 pm |
Vir Biotechnology Inc. | VIR | Virgin Herbert EVP, Research & CSO |
1,375 | $32.46 | $44,633 | 329,955 (Direct) |
View |
| 2022-01-19 Sale |
2022-01-20 5:55 pm |
Vir Biotechnology Inc. | VIR | Pang Phillip Chief Medical Officer |
5,000 | $35.06 | $175,304 | 155,368 (Direct) |
View |
| 2022-01-18 Sale |
2022-01-20 5:01 pm |
Vir Biotechnology Inc. | VIR | SATO VICKI L Director |
15,173 | $37.39 | $567,385 | 1,535,919 (Direct) |
View |
| 2022-01-11 Sale |
2022-01-13 4:09 pm |
Vir Biotechnology Inc. | VIR | Virgin Herbert EVP, Research & CSO |
1,375 | $35.1 | $48,263 | 331,330 (Direct) |
View |
| 2022-01-05 Sale |
2022-01-06 7:48 pm |
Vir Biotechnology Inc. | VIR | Pang Phillip Chief Medical Officer |
5,000 | $37.19 | $185,956 | 160,368 (Direct) |
View |
| 2021-12-28 Sale |
2021-12-30 5:00 pm |
Vir Biotechnology Inc. | VIR | Virgin Herbert EVP, Research & CSO |
1,375 | $39.95 | $54,931 | 332,705 (Direct) |
View |
| 2021-12-20 Sale |
2021-12-22 4:30 pm |
Vir Biotechnology Inc. | VIR | SVF Endurance (Cayman) Ltd SB INVESTMENT ADVISERS (UK) LTD SOFTBANK VISION FUND (AIV M1) L.P. 10% Owner |
400,022 | $52.73 | $21,093,160 | 22,216,644 (Indirect) |
View |
| 2021-12-20 Sale |
2021-12-21 6:13 pm |
Vir Biotechnology Inc. | VIR | SATO VICKI L Director |
15,174 | $54.53 | $827,485 | 1,551,092 (Direct) |
View |
| 2021-12-15 Sale |
2021-12-17 5:01 pm |
Vir Biotechnology Inc. | VIR | Pang Phillip Chief Medical Officer |
5,000 | $50.72 | $253,608 | 165,368 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-05-23 Option Award |
2022-05-25 6:12 pm |
2023-05-23 2032-05-22 |
Vir Biotechnology Inc. | VIR | SHARP PHILLIP A Director |
19,215 | $0 | 261,289 (Direct) |
View |
| 2022-05-23 Option Award |
2022-05-25 6:10 pm |
2023-05-23 2032-05-22 |
Vir Biotechnology Inc. | VIR | Napolitano Janet Director |
19,215 | $0 | 22,589 (Direct) |
View |
| 2022-05-23 Option Award |
2022-05-25 6:09 pm |
2023-05-23 2032-05-22 |
Vir Biotechnology Inc. | VIR | Sigal Charles Elliott Director |
19,215 | $0 | 22,589 (Direct) |
View |
| 2022-05-23 Option Award |
2022-05-25 6:07 pm |
2023-05-23 2032-05-22 |
Vir Biotechnology Inc. | VIR | SATO VICKI L Director |
19,215 | $0 | 1,519,304 (Direct) |
View |
| 2022-05-23 Option Award |
2022-05-25 5:53 pm |
2023-05-23 2032-05-22 |
Vir Biotechnology Inc. | VIR | PEREZ ROBERT J Director |
19,215 | $0 | 22,589 (Direct) |
View |
| 2022-05-23 Option Award |
2022-05-25 5:52 pm |
2023-05-23 2032-05-22 |
Vir Biotechnology Inc. | VIR | MORE ROBERT J Director |
19,215 | $0 | 541,356 (Direct) |
View |
| 2022-05-23 Option Award |
2022-05-25 5:51 pm |
2023-05-23 2032-05-22 |
Vir Biotechnology Inc. | VIR | Hatfield Jeffrey S. Director |
19,215 | $0 | 22,589 (Direct) |
View |
| 2022-05-23 Option Award |
2022-05-25 5:49 pm |
2023-05-23 2032-05-22 |
Vir Biotechnology Inc. | VIR | Ramasastry Saira Director |
19,215 | $0 | 20,902 (Direct) |
View |
| 2021-12-20 Other(A) |
2022-05-10 5:26 pm |
N/A N/A |
Vir Biotechnology Inc. | VIR | NELSEN ROBERT Director 10% Owner |
102,041 | $0 | 349,587 (Direct) |
View |
| 2022-03-10 Option Award |
2022-04-06 5:22 pm |
N/A 2032-03-09 |
Vir Biotechnology Inc. | VIR | SCANGOS GEORGE A President and CEO |
333,000 | $0 | 6,037,138 (Direct) |
View |
| 2022-03-10 Exercise |
2022-03-11 4:04 pm |
N/A 2028-01-26 |
Vir Biotechnology Inc. | VIR | Virgin Herbert EVP, Research & CSO |
9,000 | $0 | 394,912 (Direct) |
View |
| 2022-03-10 Exercise |
2022-03-11 4:04 pm |
N/A N/A |
Vir Biotechnology Inc. | VIR | Virgin Herbert EVP, Research & CSO |
9,000 | $1.53 | 394,912 (Direct) |
View |
| 2022-03-02 Option Award |
2022-03-08 11:35 am |
N/A 2032-03-01 |
Vir Biotechnology Inc. | VIR | Friedl-Naderer Johanna Chief Business Officer, Global |
135,000 | $0 | 135,000 (Direct) |
View |
| 2022-02-22 Option Award |
2022-02-24 9:33 pm |
N/A 2032-02-21 |
Vir Biotechnology Inc. | VIR | HANLY ANN M. Chief Technology Officer |
100,500 | $0 | 131,112 (Direct) |
View |
| 2022-02-22 Option Award |
2022-02-24 9:33 pm |
N/A 2032-02-21 |
Vir Biotechnology Inc. | VIR | Pang Phillip Chief Medical Officer |
131,000 | $0 | 220,768 (Direct) |
View |
| 2022-02-22 Option Award |
2022-02-24 9:31 pm |
N/A 2032-02-21 |
Vir Biotechnology Inc. | VIR | Rice Steven J. Chief Administrative Officer |
60,000 | $0 | 78,658 (Direct) |
View |
| 2022-02-22 Exercise |
2022-02-24 9:30 pm |
N/A 2028-01-26 |
Vir Biotechnology Inc. | VIR | Virgin Herbert EVP, Research & CSO |
1,375 | $0 | 464,912 (Direct) |
View |
| 2022-02-22 Exercise |
2022-02-24 9:30 pm |
N/A N/A |
Vir Biotechnology Inc. | VIR | Virgin Herbert EVP, Research & CSO |
1,375 | $1.53 | 464,912 (Direct) |
View |
| 2022-02-22 Option Award |
2022-02-24 9:30 pm |
N/A 2032-02-21 |
Vir Biotechnology Inc. | VIR | Virgin Herbert EVP, Research & CSO |
70,000 | $0 | 464,912 (Direct) |
View |
| 2022-02-22 Option Award |
2022-02-24 9:29 pm |
N/A 2032-02-21 |
Vir Biotechnology Inc. | VIR | Horn Howard CFO |
85,000 | $0 | 285,384 (Direct) |
View |
| 2022-02-16 Exercise |
2022-02-18 4:47 pm |
N/A 2028-04-27 |
Vir Biotechnology Inc. | VIR | Pang Phillip Chief Medical Officer |
5,000 | $0 | 142,359 (Direct) |
View |
| 2022-02-16 Exercise |
2022-02-18 4:47 pm |
N/A N/A |
Vir Biotechnology Inc. | VIR | Pang Phillip Chief Medical Officer |
5,000 | $1.53 | 142,359 (Direct) |
View |
Ownership |
2022-02-14 4:08 pm |
N/A N/A |
Vir Biotechnology Inc. | VIR | SCANGOS GEORGE A President and CEO |
0 | $0 | 1,132,874 (Indirect) |
View |
| 2021-02-16 Ownership |
2022-02-14 4:08 pm |
N/A N/A |
Vir Biotechnology Inc. | VIR | SCANGOS GEORGE A President and CEO |
7,374,422 | $0 | 1,132,874 (Direct) |
View |
| 2022-02-08 Exercise |
2022-02-09 6:58 pm |
N/A 2028-01-26 |
Vir Biotechnology Inc. | VIR | Virgin Herbert EVP, Research & CSO |
1,375 | $0 | 328,580 (Direct) |
View |
| 2022-02-08 Exercise |
2022-02-09 6:58 pm |
N/A N/A |
Vir Biotechnology Inc. | VIR | Virgin Herbert EVP, Research & CSO |
1,375 | $1.53 | 328,580 (Direct) |
View |
| 2022-02-02 Exercise |
2022-02-04 5:03 pm |
N/A 2028-04-27 |
Vir Biotechnology Inc. | VIR | Pang Phillip Chief Medical Officer |
5,000 | $0 | 150,368 (Direct) |
View |
| 2022-02-02 Exercise |
2022-02-04 5:03 pm |
N/A N/A |
Vir Biotechnology Inc. | VIR | Pang Phillip Chief Medical Officer |
5,000 | $1.53 | 150,368 (Direct) |
View |
| 2022-01-25 Exercise |
2022-01-26 7:35 pm |
N/A 2028-01-26 |
Vir Biotechnology Inc. | VIR | Virgin Herbert EVP, Research & CSO |
1,375 | $0 | 329,955 (Direct) |
View |
| 2022-01-25 Exercise |
2022-01-26 7:35 pm |
N/A N/A |
Vir Biotechnology Inc. | VIR | Virgin Herbert EVP, Research & CSO |
1,375 | $1.53 | 329,955 (Direct) |
View |
| 2022-01-19 Exercise |
2022-01-20 5:55 pm |
N/A 2028-04-27 |
Vir Biotechnology Inc. | VIR | Pang Phillip Chief Medical Officer |
5,000 | $0 | 155,368 (Direct) |
View |
| 2022-01-19 Exercise |
2022-01-20 5:55 pm |
N/A N/A |
Vir Biotechnology Inc. | VIR | Pang Phillip Chief Medical Officer |
5,000 | $1.53 | 155,368 (Direct) |
View |
| 2022-01-11 Exercise |
2022-01-13 4:09 pm |
N/A 2028-01-26 |
Vir Biotechnology Inc. | VIR | Virgin Herbert EVP, Research & CSO |
1,375 | $0 | 331,330 (Direct) |
View |
| 2022-01-11 Exercise |
2022-01-13 4:09 pm |
N/A N/A |
Vir Biotechnology Inc. | VIR | Virgin Herbert EVP, Research & CSO |
1,375 | $1.53 | 331,330 (Direct) |
View |
| 2022-01-05 Exercise |
2022-01-06 7:48 pm |
N/A 2018-04-27 |
Vir Biotechnology Inc. | VIR | Pang Phillip Chief Medical Officer |
5,000 | $0 | 160,368 (Direct) |
View |
| 2022-01-05 Exercise |
2022-01-06 7:48 pm |
N/A N/A |
Vir Biotechnology Inc. | VIR | Pang Phillip Chief Medical Officer |
5,000 | $1.53 | 160,368 (Direct) |
View |
| 2021-12-28 Exercise |
2021-12-30 5:00 pm |
N/A 2028-01-26 |
Vir Biotechnology Inc. | VIR | Virgin Herbert EVP, Research & CSO |
1,375 | $0 | 332,705 (Direct) |
View |
| 2021-12-28 Exercise |
2021-12-30 5:00 pm |
N/A N/A |
Vir Biotechnology Inc. | VIR | Virgin Herbert EVP, Research & CSO |
1,375 | $1.53 | 332,705 (Direct) |
View |
| 2021-12-20 Other |
2021-12-22 6:00 pm |
N/A N/A |
Vir Biotechnology Inc. | VIR | NELSEN ROBERT Director 10% Owner |
1,852,041 | $0 | 12,773,496 (Indirect) |
View |
| 2021-12-20 Other |
2021-12-22 5:59 pm |
N/A N/A |
Vir Biotechnology Inc. | VIR | ARCH Venture Partners IX LLC ARCH Venture Partners IX L.P. ARCH Venture Partners IX Overage L.P. ARCH Venture Fund IX L.P. ARCH Venture Fund IX Overage L.P. CRANDELL KEITH BYBEE CLINTON 10% Owner |
1,811,207 | $0 | 12,527,079 (Indirect) |
View |
| 2021-12-15 Exercise |
2021-12-17 5:01 pm |
N/A 2018-04-27 |
Vir Biotechnology Inc. | VIR | Pang Phillip Chief Medical Officer |
5,000 | $0 | 165,368 (Direct) |
View |
| 2021-12-15 Exercise |
2021-12-17 5:01 pm |
N/A N/A |
Vir Biotechnology Inc. | VIR | Pang Phillip Chief Medical Officer |
5,000 | $1.53 | 165,368 (Direct) |
View |